Aggressive medical treatment in PAD
Should aggressive medical treatment be used in every patient with peripheral artery disease (PAD), or should it be adjusted to disease severity?
Should aggressive medical treatment be used in every patient with peripheral artery disease (PAD), or should it be adjusted to disease severity?
Do you have any suggestions or recommendations on diagnostic workup of peripheral artery disease (PAD) performed by a general practitioner or another nonvascular specialist?
Is perioperative myocardial infarction (MI) an important issue? Do we have any methods for prevention and treatment?
Are elevated troponin levels a relevant finding in the intensive care unit (ICU)?
What is the recommended antiplatelet therapy in a patient with type 2 myocardial infarction (MI)?
Should the management of myocardial infarction (MI) vary depending on the patient’s age?
What is the current approach to the treatment of hypertension in elderly patients?
Should revascularization procedures in chronic limb ischemia be limited in older patients depending on their age or performance status?
Is there still a role for creatine kinase (CK) or creatine kinase–myocardial band (CK-MB) in a patient with suspected myocardial infarction (MI)?
When should we start pharmacotherapy in young patients with hypertension and no other cardiovascular risk factors?